Adage Capital Partners
SPRB

Adage Capital Partners’s Spruce Biosciences SPRB Stock Holding History

Adage Capital Partners’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,207
Closed -$2.7M – 1082
2021
Q2 		$2.7M Sell
3,207
-666
-17% -$711K 0.01% 866
2021
Q1 		$4.82M Hold
3,873
– – 0.01% 803
2020
Q4 		$7.06M Buy
+3,873
New +$6.42M 0.02% 648

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Adage Capital Partners's SPRB Position: Q3 2021 in Review

Adage Capital Partners sold out of Spruce Biosciences (SPRB) in Q3 2021, closing a stake of 3,207 shares — an estimated $2.7M sold.

Adage Capital Partners first reported a position in SPRB in Q4 2020 and held it in 3 quarters. The position peaked at $7.06M in Q4 2020. 43 funds tracked by Wall St. Rank hold SPRB as of Q3 2021.

  • Adage Capital Partners reported no remaining Spruce Biosciences position as of Q3 2021 after selling out during the quarter.
  • Adage Capital Partners sold 3,207 Spruce Biosciences shares in Q3 2021, an estimated $2.7M.
  • Adage Capital Partners first reported a position in Spruce Biosciences in Q4 2020 and held it in 3 quarters.
  • Adage Capital Partners's Spruce Biosciences position peaked at $7.06M in Q4 2020.
  • 43 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2021.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.